Werewolf Therapeutics, Inc. (HOWL)
Market Closed
16 Jun, 20:00
NASDAQ (NGS) NASDAQ (NGS) Primary $
0. 36
-0.03
-7.4312%
After Hours
$
+0.04 +11.1111% 0. 40
18.52M Market Cap
- P/E Ratio
- Div Yield
564,219 Volume
-1.32 Eps
$ 0.39
Previous Close Want to track HOWL and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
HOWL Earnings Reports FAQ
What is the earnings per share (EPS) for HOWL?
The current EPS is -1.32.
What is the company's earnings growth rate?
Werewolf Therapeutics, Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Werewolf Therapeutics, Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Werewolf Therapeutics, Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for HOWL at this time, as Werewolf Therapeutics, Inc has no recent EPS data to calculate it.
